Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma

Lung squamous cell carcinoma (LUSC) is the second major type of lung cancer globally. The majority of patients with LUSC are clinically diagnosed at the advanced stages, thus it is urgent to identify suitable prognostic markers for LUSC. B-cell lymphoma 2 (Bcl-2) has been widely studied in non-small...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Feng, Changjiang, Wu, Jiaqi, Yang, Fan, Qiu, Mangtang, Hu, Shuofeng, Guo, Saisai, Wu, Jin, Ying, Xiaomin, Wang, Jun
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2018
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5920356/
https://ncbi.nlm.nih.gov/pubmed/29725421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8198
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados